Inventor · disambiguated record
Peter Ellmark
Also filed as: ELLMARK PETER · ELLMARK PETER BO JOAKIM
21 granted patents·10 pending applications·59 citations·filing 2006–2023
93Inventor score
Files withALLIGATOR BIOSCIENCE AB24APTEVO RES & DEVELOPMENT LLC3BORREBAECK CARL ARNE KRISTER1ELLMARK PETER BO JOAKIM1HARALDSSON KARIN1
Top patents by PatentIndex Score
31 records- 0191US11873348B2PeptidesALLIGATOR BIOSCIENCE AB·Filed 2022·Granted Jan 16, 2024·4 cites·7 claims
- 0291US11535678B2Anti-CD137 antibodies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2017·Granted Dec 27, 2022·8 cites·18 claims
- 0390US10689454B2Anti-CD137 antibodies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2019·Granted Jun 23, 2020·4 cites·17 claims
- 0490US10239949B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Mar 26, 2019·6 cites·20 claims
- 0588US10414815B2scFV antibody libraryALLIGATOR BIOSCIENCE AB·Filed 2015·Granted Sep 17, 2019·9 cites·7 claims
- 0686US11312786B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Granted Apr 26, 2022·2 cites·19 claims
- 0785US9486520B2Compositions comprising polyglutamic acid nanoparticles and CD40 agonistsBORREBAECK CARL ARNE KRISTER·Filed 2011·Granted Nov 8, 2016·11 cites·10 claims
- 0883US9676862B2Anti-CD40 antibodies and methods of treating cancerELLMARK PETER BO JOAKIM·Filed 2012·Granted Jun 13, 2017·12 cites·18 claims
- 0980US11008396B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2016·Granted May 18, 2021·2 cites·10 claims
- 1078US12509526B2Anti-CD137 antibodies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2022·Granted Dec 30, 2025·0 cites·19 claims
- 1175US12448465B2PeptidesALLIGATOR BIOSCIENCE AB·Filed 2023·Granted Oct 21, 2025·0 cites·14 claims
- 1272US11780928B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Oct 10, 2023·0 cites·15 claims
- 1366US12173082B2Bispecific polypeptides against CD137ALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Dec 24, 2024·0 cites·17 claims
- 1466US10577425B2Anti-CD40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2014·Granted Mar 3, 2020·1 cites·8 claims
- 1566US2021403589A1Combination therapies with anti cd40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2021·Application pending·0 cites
- 1665US11725060B2Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Aug 15, 2023·0 cites·24 claims
- 1765US10774150B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2020·Granted Sep 15, 2020·0 cites·12 claims
- 1858US2024287199A1Novel combination therapies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2022·Application pending·0 cites
- 1957US12415862B2Methods and compositionsALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Sep 16, 2025·0 cites·20 claims
- 2054US11149090B2Combination therapies with anti CD40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2015·Granted Oct 19, 2021·0 cites·16 claims
- 2153US10640567B2Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cellsALLIGATOR BIOSCIENCE AB·Filed 2017·Granted May 5, 2020·0 cites·20 claims
- 2252US9834589B2CD86 variants with improved affinity for CTLA-4ALLIGATOR BIOSCIENCE AB·Filed 2014·Granted Dec 5, 2017·0 cites·6 claims
- 2347US2022073635A1Novel polypeptidesALLIGATOR BIOSCIENCE AB·Filed 2019·Application pending·0 cites
- 2447US2022064325A1Novel polypeptidesALLIGATOR BIOSCIENCE AB·Filed 2019·Application pending·0 cites
- 2543US2019169308A1Novel bispecific polypeptides against cd137ALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
- 2643US2017304437A1Bispecific molecules capable of specifically binding to both ctla-4 and cd40ALLIGATOR BIOSCIENCE AB·Filed 2014·Application pending·0 cites
- 2742US2020048358A1Bispecific antibody against ox40 and ctla-4ALLIGATOR BIOSCIENCE AB·Filed 2018·Application pending·0 cites
- 2838US2009203572A1Method for in Vitro Molecular Evolution of Protein FunctionHARALDSSON KARIN·Filed 2006·Application pending·0 cites
- 2938US2019161555A1Bispecific Antibodies Directed Against OX40 and a Tumor-Associated AntigenALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
- 3037US2019309084A1Bispecific Polypeptides to GITR and CTLA-4ALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
- 3126US8685640B2Medical methods and agents for use thereinTOETTERMAN THOMAS·Filed 2010·Granted Apr 1, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Peter Ellmark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →